This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2012
  • /
  • 11
  • /
  • European Commission rejects Uplyso( Pfizer/Protali...
Drug news

European Commission rejects Uplyso( Pfizer/Protalix) for Gaucher Disease

Read time: 1 mins
Last updated:9th Nov 2012
Published:9th Nov 2012
Source: Pharmawand
The European Commission has rejected Uplyso (taliglucerase alfa ) for Gaucher Disease as a grant of approval would breach the Orphan drug status of Vpriv (velaglucerase alfa) from Shire which has 10 years exclusivity from August 2010.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Related news and insights